[go: up one dir, main page]

MX2010004045A - Compuestos novedosos de mimeticos de giro inverso, y su uso (1). - Google Patents

Compuestos novedosos de mimeticos de giro inverso, y su uso (1).

Info

Publication number
MX2010004045A
MX2010004045A MX2010004045A MX2010004045A MX2010004045A MX 2010004045 A MX2010004045 A MX 2010004045A MX 2010004045 A MX2010004045 A MX 2010004045A MX 2010004045 A MX2010004045 A MX 2010004045A MX 2010004045 A MX2010004045 A MX 2010004045A
Authority
MX
Mexico
Prior art keywords
reverse
novel compounds
prodrugs
reverse turn
compounds
Prior art date
Application number
MX2010004045A
Other languages
English (en)
Inventor
Sang-Hak Lee
Jae Uk Chung
Hee-Kyung Jung
Kyung-Yun Jung
Min-Wook Jeong
Hyun-Ju La
Hoe-Moon Kim
Original Assignee
Choongwae Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choongwae Pharma Corp filed Critical Choongwae Pharma Corp
Publication of MX2010004045A publication Critical patent/MX2010004045A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describen compuestos restringidos conformacionalmente que son novedosos y reproducen o imitan la estructura secundaria de regiones de giro inverso de péptidos y proteínas biológicamente activos, y que tienen un andamiaje bicíclico, así como sus derivados, incluyendo los profármacos. Dichas estructuras miméticas de giro inverso y dichos profármacos tienen utilidad en una gama amplia de campos, incluyendo el uso como agentes de diagnóstico y terapéuticos. La invención se refiere también a un uso de dichos compuestos para la preparación de un medicamento para tratar o prevenir el cáncer, incluyendo una leucemia mieloide aguda.
MX2010004045A 2007-10-15 2008-10-15 Compuestos novedosos de mimeticos de giro inverso, y su uso (1). MX2010004045A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/974,941 US7671054B1 (en) 2001-10-12 2007-10-15 Reverse-turn mimetics and method relating thereto
PCT/KR2008/006072 WO2009051399A2 (en) 2007-10-15 2008-10-15 Novel compounds of reverse turn mimetics and the use thereof (1)

Publications (1)

Publication Number Publication Date
MX2010004045A true MX2010004045A (es) 2010-07-06

Family

ID=40567948

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2010004046A MX2010004046A (es) 2007-10-15 2008-10-15 Compuestos novedosos de mimeticos de giro inverso y su uso (3).
MX2010004045A MX2010004045A (es) 2007-10-15 2008-10-15 Compuestos novedosos de mimeticos de giro inverso, y su uso (1).

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2010004046A MX2010004046A (es) 2007-10-15 2008-10-15 Compuestos novedosos de mimeticos de giro inverso y su uso (3).

Country Status (13)

Country Link
US (4) US7671054B1 (es)
EP (3) EP2212328B1 (es)
JP (3) JP5222949B2 (es)
KR (3) KR101269420B1 (es)
CN (4) CN101827850B (es)
AU (2) AU2008312193B2 (es)
BR (2) BRPI0818511B1 (es)
CA (2) CA2701735C (es)
ES (3) ES2541459T3 (es)
MX (2) MX2010004046A (es)
PL (1) PL2212330T3 (es)
RU (2) RU2470024C2 (es)
WO (3) WO2009051399A2 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3211496B2 (ja) 1993-07-30 2001-09-25 日産自動車株式会社 表面潤滑皮膜処理材およびその製造方法
US7232822B2 (en) * 2001-10-12 2007-06-19 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7576084B2 (en) * 2001-10-12 2009-08-18 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7566711B2 (en) * 2001-10-12 2009-07-28 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7671054B1 (en) * 2001-10-12 2010-03-02 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US8080657B2 (en) * 2001-10-12 2011-12-20 Choongwae Pharma Corporation Compounds of reverse turn mimetics and the use thereof
CA2629136C (en) * 2005-11-08 2016-03-08 Choongwae Pharma Corporation .alpha.-helix mimetics and method relating to the treatment of cancer stem cells
AU2009255042B2 (en) * 2008-06-06 2014-05-15 Prism Biolab Corporation Alpha helix mimetics and methods relating thereto
EP2346871A1 (en) 2008-10-14 2011-07-27 PRISM BioLab Corporation Alpha helix mimetics in the treatment of cancer
RU2515983C2 (ru) * 2009-04-15 2014-05-20 Джей ДаблЮ ФАРМАСЬЮТИКАЛ КОРПОРЭЙШН Новые соединения миметиков обратного действия, способ их получения и применения
CN102482258B (zh) * 2009-05-07 2014-06-25 株式会社棱镜制药 α-螺旋模拟物和与其相关的方法
JPWO2011096440A1 (ja) 2010-02-03 2013-06-10 株式会社 ＰＲＩＳＭ ＢｉｏＬａｂ 天然変性タンパク質に結合する化合物およびそのスクリーニング方法
KR102168006B1 (ko) 2010-10-07 2020-10-20 유니버시티 오브 써던 캘리포니아 체세포 줄기 세포의 비대칭 분열을 향상시키기 위한 ｃｂｐ/카테닌 길항제
EP2628741B1 (en) * 2010-10-14 2015-10-07 JW Pharmaceutical Corporation Novel compound of a reverse-turn mimetic and a production method and use therefor
BR112013012228B1 (pt) 2010-11-16 2023-02-28 University Of Southern California Método cosmético para tratar uma condição da pele e usos de um composto antagonista de cbp/catenina de molécula pequena
EP2678341A1 (en) * 2011-02-25 2014-01-01 PRISM Pharma Co., Ltd. Alpha helix mimetics and methods relating thereto
US20140005164A1 (en) * 2011-04-04 2014-01-02 Siena Biotech S.P.A. Wnt pathway antagonists
KR101441406B1 (ko) * 2011-05-25 2014-11-04 주식회사 바이오이미징코리아 디아릴이오도늄 염 전구체를 이용한 플로오린-18이 표지된 플루마제닐의 제조 방법
US9353119B2 (en) * 2011-08-09 2016-05-31 Jw Pharmaceutical Corporation Composition for preventing and treating non-small cell lung cancer, containing pyrazino-triazine derivatives
PT2754441E (pt) * 2011-08-09 2016-06-24 Jw Pharmaceutical Corp Composição para a prevenção e tratamento de cancro do pulmão de não pequenas células, contendo derivados de pirazino-triazina
US20140179633A1 (en) * 2011-08-26 2014-06-26 Jw Pharmaceutical Corporation Composition comprising pyrazino-triazine derivatives
HK1201061A1 (en) 2011-10-07 2015-08-21 University Of Southern California Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
GB201315335D0 (en) 2013-08-29 2013-10-09 Of Singapore Amino diacids containing peptide modifiers
WO2015037587A1 (ja) * 2013-09-11 2015-03-19 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピラジノ［２，１－ｃ］［１，２，４］トリアジン化合物の製造方法
US9174998B2 (en) 2013-12-25 2015-11-03 Eisai R&D Management Co., Ltd. (6S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-8-({6-[3-(piperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-2-(prop-2-en-1-yl)-octahydro-1H-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide compound
MX373231B (es) 2015-06-16 2020-05-08 Eisai R&D Man Co Ltd Agente anticancerigeno.
KR102559211B1 (ko) * 2015-06-23 2023-07-25 에자이 알앤드디 매니지먼트 가부시키가이샤 (6S,9aS)-N-벤질-8-({6-[3-(4-에틸피페라진-1-일)아제티딘-1-일]피리딘-2-일}메틸)-6-(2-플루오로-4-하이드록시벤질)-4,7-디옥소-2-(프로프-2-엔-1-일)헥사하이드로-2H-피라지노[2,1-c][1,2,4]트리아진-1(6H)-카복사마이드의 결정
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
CN108026104B (zh) * 2015-09-18 2021-06-18 国立大学法人鸟取大学 利用低分子化合物的癌及纤维化的抑制和再生促进的效果
WO2017184808A1 (en) * 2016-04-20 2017-10-26 University Of Southern California Compounds and methods for increasing hematopoiesis
JP6581320B2 (ja) 2017-02-08 2019-09-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 腫瘍治療用医薬組成物
RU2019134940A (ru) 2017-05-16 2021-06-16 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Лечение гепатоцеллюлярной карциномы
CN110950873A (zh) * 2019-12-10 2020-04-03 河南大学 坡尔吲哚的合成新方法
WO2021183791A1 (en) 2020-03-12 2021-09-16 City Of Hope Wnt/cbp/catenin signaling pathway inhibitors and uses thereof
JP7750851B2 (ja) 2020-03-12 2025-10-07 ３＋２ ファーマ リミテッド ライアビリティ カンパニー Ｃｂｐ／カテニンシグナル伝達経路阻害薬およびそれらの使用
US20240352020A1 (en) * 2021-08-26 2024-10-24 3+2 Pharma, Llc Pyrazole-containing cbp/catenin antagonists and uses thereof
GB202209228D0 (en) 2022-06-23 2022-08-10 Univ Strathclyde Modified amino acids and uses thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3120859A1 (de) 1981-05-26 1982-12-23 Basf Ag, 6700 Ludwigshafen Dihalogenacetamide, verfahren zu ihrer herstellung und herbizide mittel, die acetanilide als herbizide wirkstoffe und diese dihalogenacetamide als antagonistische mittel enthalten
US5475085A (en) 1991-02-07 1995-12-12 Molecumetics, Ltd. Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
EP0573608A1 (en) 1991-02-07 1993-12-15 Molecumetics, Ltd. Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
JPH07509723A (ja) 1992-08-06 1995-10-26 モレキュメティクス，リミティド 反転型ターンの立体配座的に拘束されたミメティックスと前者を含有するペプチド
US5446128A (en) 1993-06-18 1995-08-29 The Board Of Trustees Of The University Of Illinois Alpha-helix mimetics and methods relating thereto
US5693325A (en) 1994-03-15 1997-12-02 Molecumetics, Ltd. Peptide vaccines and methods relating thereto
US6020331A (en) 1995-03-24 2000-02-01 Molecumetics, Ltd. β-sheet mimetics and use thereof as protease inhibitors
US6245764B1 (en) 1995-03-24 2001-06-12 Molecumetics Ltd. β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
US5929237A (en) 1995-10-27 1999-07-27 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
US5840833A (en) 1995-10-27 1998-11-24 Molecumetics, Ltd Alpha-helix mimetics and methods relating thereto
US6184223B1 (en) 1995-10-27 2001-02-06 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
US6013458A (en) 1995-10-27 2000-01-11 Molecumetics, Ltd. Reverse-turn mimetics and methods relating thereto
ATE320811T1 (de) 1996-08-05 2006-04-15 Myriad Genetics Inc Verwendung von beta-blatt mimetika als protease und kinase hemmer und alshemmer eines transkriptionsfaktors
US6117896A (en) 1997-02-10 2000-09-12 Molecumetics Ltd. Methods for regulating transcription factors
US6451972B1 (en) 1998-11-16 2002-09-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors
US6294525B1 (en) 1999-09-01 2001-09-25 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
CA2284459C (en) 1999-10-04 2012-12-11 Neokimia Inc. Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
US6872825B2 (en) 1999-12-21 2005-03-29 The Procter & Gamble Company Peptide β-turn mimetic compounds and processes for making them
DE10005631A1 (de) 2000-02-09 2001-08-23 Max Planck Gesellschaft Arginin-Mimetika als Faktor X¶a¶-Inhibitoren
US7662960B2 (en) 2001-04-26 2010-02-16 Choongwae Pharma Corporation Beta-strand mimetics and method relating thereto
US20040204477A1 (en) 2001-07-09 2004-10-14 Juergen Moll Interaction inhibitors of tcf-4 with beta-catenin
WO2003030907A1 (en) * 2001-10-09 2003-04-17 Myriad Genetics, Inc. Reverse-turn mimetics and composition and methods relating thereto
US7232822B2 (en) * 2001-10-12 2007-06-19 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US20040072831A1 (en) * 2001-10-12 2004-04-15 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7576084B2 (en) 2001-10-12 2009-08-18 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
JP4387793B2 (ja) * 2001-10-12 2009-12-24 チョンウェ ファーマ コーポレーション 逆向ターンミメティックおよびそれに関連した方法
US7566711B2 (en) * 2001-10-12 2009-07-28 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US7671054B1 (en) * 2001-10-12 2010-03-02 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
US6762185B1 (en) 2002-03-01 2004-07-13 Choongwae Pharma Corporation Compounds useful for treatment of cancer, compositions containing the same, and methods of their use
JP2006517550A (ja) 2003-02-13 2006-07-27 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 置換ヘキサヒドロピラジノ［１，２−ａ］ピリミジン−４，７−ジオン誘導体、その製造方法および医薬としてのその使用
RS20050572A (sr) 2003-02-13 2007-09-21 Sanofi-Aventis Deutschland Gmbh., AZOTOM SUPSTITUISANI HEKSAHIDRO- PIRAZINO(1,2-A)PIRIMIDIN -4,7-DION DERIVATI, POSTUPAK ZA NjIHOVU PROIZVODNjU I NjIHOVA PRIMENA KAO LEKA
KR20060121842A (ko) * 2003-08-28 2006-11-29 주식회사 중외제약 β-카테닌/ＴＣＦ에 의해 활성화되는 전사의 조절
CA2629136C (en) 2005-11-08 2016-03-08 Choongwae Pharma Corporation .alpha.-helix mimetics and method relating to the treatment of cancer stem cells
JP2009517085A (ja) 2005-11-28 2009-04-30 チョンウェ ファーマ コーポレイション 培養における細胞の無血清増殖
AU2009255042B2 (en) 2008-06-06 2014-05-15 Prism Biolab Corporation Alpha helix mimetics and methods relating thereto

Also Published As

Publication number Publication date
US20100240662A1 (en) 2010-09-23
WO2009051399A3 (en) 2009-06-04
ES2509042T3 (es) 2014-10-16
JP5222948B2 (ja) 2013-06-26
CA2702461A1 (en) 2009-04-23
CN103539797B (zh) 2016-05-18
RU2010119447A (ru) 2011-11-27
AU2008312193B2 (en) 2012-10-18
JP2011500668A (ja) 2011-01-06
WO2009051397A2 (en) 2009-04-23
BRPI0818511B1 (pt) 2021-09-21
RU2010119468A (ru) 2011-11-27
CA2701735A1 (en) 2009-04-23
EP2212329A4 (en) 2011-11-30
EP2212330A2 (en) 2010-08-04
US8049008B2 (en) 2011-11-01
WO2009051397A3 (en) 2009-06-04
EP2212330B1 (en) 2015-04-08
EP2212328A2 (en) 2010-08-04
EP2212330A4 (en) 2011-11-30
ES2541459T3 (es) 2015-07-20
CN101827850B (zh) 2014-03-12
US8138337B2 (en) 2012-03-20
WO2009051397A9 (en) 2010-05-27
WO2009051398A2 (en) 2009-04-23
AU2008312193A1 (en) 2009-04-23
BRPI0818647B1 (pt) 2021-10-26
MX2010004046A (es) 2010-06-25
CN101896485A (zh) 2010-11-24
JP5222949B2 (ja) 2013-06-26
US7671054B1 (en) 2010-03-02
WO2009051398A3 (en) 2009-06-04
AU2008312191B2 (en) 2012-07-05
JP2011500666A (ja) 2011-01-06
KR20100099116A (ko) 2010-09-10
CA2701735C (en) 2012-12-11
ES2622703T3 (es) 2017-07-07
CA2702461C (en) 2012-12-11
EP2212328A4 (en) 2011-11-30
CN101827849B (zh) 2013-07-24
RU2457210C2 (ru) 2012-07-27
CN103539797A (zh) 2014-01-29
PL2212330T3 (pl) 2015-09-30
CN101827850A (zh) 2010-09-08
US20100222303A1 (en) 2010-09-02
CN101827849A (zh) 2010-09-08
JP5400785B2 (ja) 2014-01-29
EP2212329A2 (en) 2010-08-04
EP2212329B1 (en) 2014-07-30
AU2008312191A1 (en) 2009-04-23
RU2470024C2 (ru) 2012-12-20
KR101229504B1 (ko) 2013-02-04
BRPI0818511A2 (pt) 2015-06-16
KR20100085107A (ko) 2010-07-28
US20100228027A1 (en) 2010-09-09
US8071764B2 (en) 2011-12-06
KR101542921B1 (ko) 2015-08-11
KR20100085102A (ko) 2010-07-28
WO2009051399A2 (en) 2009-04-23
EP2212328B1 (en) 2017-01-25
BRPI0818647A2 (pt) 2015-04-07
KR101269420B1 (ko) 2013-05-30
JP2011500667A (ja) 2011-01-06

Similar Documents

Publication Publication Date Title
MX2010004045A (es) Compuestos novedosos de mimeticos de giro inverso, y su uso (1).
DK1869049T3 (da) Imidazopyridazinforbindelser
MX2009011615A (es) Acidos benzoilamino-indan-2-carboxilicos sustituidos y compuestos relacionados.
GT201300121A (es) Derivados de 2,3-dihidroimidazo(1,2-c)quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis
TN2009000439A1 (en) Substituted benzoylamino-indian-2-carboxylic acids and related compounds
ECSP067043A (es) Derivados de pirrolotriazina útiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogénesis
UA86063C2 (ru) Липосомы для снабжения лекарств
EA201070597A1 (ru) Антибактериальные аналоги аминогликозида
SG160364A1 (en) Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
MX354173B (es) Fluorometil-5,6-dihidro-4h-[1,3]oxazinas.
CL2011000119A1 (es) Compuestos derivados de triazolo[4,3-a]piridina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
EP2510941A3 (en) Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
ZA201000581B (en) 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
WO2002092010A3 (en) Reverse-turn mimetics and methods relating thereto
EP1812112A4 (en) CHEMICAL COMPOUNDS
MX2009005125A (es) Pirrolo[1,2-a]imidazoldiona efectiva en el tratamiento de neurotoxicidad periferica inducida por agentes quimioterapeuticos.
UA97505C2 (ru) ПРИМЕНЕНИЕ N-[2-(2,1,3-БЕНЗОТИАДИАЗОЛ-5-ИЛАМИНО)-6-(2,6-ДИХЛОРФЕНИЛ)ПИРИДО[2,3-d]ПИРИМИДИН-7-ИЛ]-N'-(1,1-ДИМЕТИЛЭТИЛ)-МОЧЕВИНЫ ДЛЯ ЛЕЧЕНИЯ МИЕЛОЛЕЙКОЗОВ
ATE475408T1 (de) Formulierungen von tipifarnib zur intravenösen verabreichung
ATE428713T1 (de) Beta-strang-mimetika
DE602006018883D1 (de) Tricylische 1,2,4-triazinoxide und zusammensetzungen davon zur therapeutischen anwendung bei krebsbehandlungen
MY148611A (en) Imino-imidazo-pyridine derivatives having antithrombotic activity
TW200720239A (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
WO2006005142A3 (en) Mono- and polycyclic compounds with therapeutic activity, pharmaceutical compositions including them and intermediates for making them
TW200744596A (en) Antitumor agents

Legal Events

Date Code Title Description
FG Grant or registration